Filters: Author is Sullivan, Lynn E [Clear All Filters]
"Effect of incarceration history on outcomes of primary care office-based buprenorphine/naloxone." Journal of general internal medicine 25, no. 7 (2010): 670-4. Abstract
"Food insecurity is associated with poor virologic response among HIV-infected patients receiving antiretroviral medications." Journal of general internal medicine 26, no. 9 (2011): 1012-8. Abstract
"Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S62-7. Abstract
"Substance use in patients with sexually transmitted infections: results from a national U.S. survey." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 6 (2010): 504-9. Abstract
"Gender and non-medical use of prescription opioids: results from a national US survey." Addiction (Abingdon, England) 103, no. 2 (2008): 258-68. Abstract
"Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone." Alcoholism, clinical and experimental research 36, no. 2 (2012): 318-24. Abstract
"Association Between Risk Behaviors and Antiretroviral Resistance in HIV-Infected Patients Receiving Opioid Agonist Treatment." Journal of addiction medicine (2013). Abstract
"Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users." Addiction (Abingdon, England) 100, no. 2 (2005): 150-8. Abstract
"Initial strategies for integrating buprenorphine into HIV care settings in the United States." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S191-6. Abstract
"Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors." Journal of substance abuse treatment 35, no. 1 (2008): 87-92. Abstract
"Alcohol consumption and depressive symptoms over time: a longitudinal study of patients with and without HIV infection." Drug and alcohol dependence 117, no. 2-3 (2011): 158-63. Abstract
"The impact of alcohol use on depressive symptoms in human immunodeficiency virus-infected patients." Addiction (Abingdon, England) 103, no. 9 (2008): 1461-7. Abstract
"The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?" Drug and alcohol dependence 79, no. 1 (2005): 113-6. Abstract
"Hepatitis C and HIV infections: implications for clinical care in injection drug users." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 13, no. 1 (2004): 1-20. Abstract
"Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 41, no. 6 (2005): 891-6. Abstract
"A meta-analysis of the efficacy of nonphysician brief interventions for unhealthy alcohol use: implications for the patient-centered medical home." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 20, no. 4 (2011): 343-56. Abstract
"A trial of integrated buprenorphine/naloxone and HIV clinical care." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S184-90. Abstract
"The prevalence and impact of alcohol problems in major depression: a systematic review." The American journal of medicine 118, no. 4 (2005): 330-41. Abstract
"The impact of cocaine use on outcomes in HIV-infected patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S54-61. Abstract
"The association between cocaine use and treatment outcomes in patients receiving office-based buprenorphine/naloxone for the treatment of opioid dependence." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 1 (2010): 53-8. Abstract
"Training HIV physicians to prescribe buprenorphine for opioid dependence." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 13-8. Abstract
"Narrative review: buprenorphine for opioid-dependent patients in office practice." Annals of internal medicine 148, no. 9 (2008): 662-70. Abstract
"The case for routine HIV screening and impact of managed care." The American journal of managed care 16, no. 13 Suppl (2010): S345-51. Abstract
"Factors affecting willingness to provide buprenorphine treatment." Journal of substance abuse treatment 36, no. 3 (2009): 244-51. Abstract
"Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients." Journal of general internal medicine 22, no. 4 (2007): 527-30. Abstract
"Counseling and directly observed medication for primary care buprenorphine maintenance: a pilot study." Journal of addiction medicine 6, no. 3 (2012): 205-11. Abstract
"Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 19, no. 1 (2010): 4-16. Abstract
"General internists' beliefs, behaviors, and perceived barriers to routine HIV screening in primary care." AIDS education and prevention : official publication of the International Society for AIDS Education 23, no. 3 Suppl (2011): 70-83. Abstract
"Knowledge and Perceptions of HIV-Infected Patients Regarding HIV Transmission and Treatment in Ho Chi Minh City, Vietnam." Asia-Pacific journal of public health / Asia-Pacific Academic Consortium for Public Health (2011). Abstract
"Evaluation of a combined online and in person training in the use of buprenorphine." Substance abuse : official publication of the Association for Medical Education and Research in Substance Abuse 27, no. 3 (2006): 39-45. Abstract
"Oral substitution treatment of injecting opioid users for prevention of HIV infection." Cochrane database of systematic reviews (Online), no. 8 (2011): CD004145. Abstract
"Brief report: Methadone treatment of injecting opioid users for prevention of HIV infection." Journal of general internal medicine 21, no. 2 (2006): 193-5. Abstract
"Update in addiction medicine for the generalist." Journal of general internal medicine 22, no. 8 (2007): 1190-4.
"Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence." The New England journal of medicine 355, no. 4 (2006): 365-74. Abstract
"A Randomized Trial of Cognitive Behavioral Therapy in Primary Care-based Buprenorphine." The American journal of medicine 126, no. 1 (2013): 74.e11-7. Abstract
"Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S33-8. Abstract
"Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years." The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 17, no. 2 (2008): 116-20. Abstract
"Human Immunodeficiency Virus-Testing Practices Among Buprenorphine-prescribing Physicians." Journal of addiction medicine (2012). Abstract
"Human immunodeficiency virus testing practices among buprenorphine-prescribing physicians." Journal of addiction medicine 6, no. 2 (2012): 159-65. Abstract
"Update in HIV medicine for the generalist." Journal of general internal medicine 26, no. 5 (2011): 538-42.
"Factors affecting clinician educator encouragement of routine HIV testing among trainees." Journal of general internal medicine 27, no. 7 (2012): 839-44. Abstract
"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates." Drug and alcohol dependence 94, no. 1-3 (2008): 38-47. Abstract
"Provider and practice characteristics associated with use of rapid HIV Testing by general internists." Journal of general internal medicine 26, no. 11 (2011): 1258-64. Abstract
"Patient satisfaction with primary care office-based buprenorphine/naloxone treatment." Journal of general internal medicine 22, no. 2 (2007): 242-5. Abstract
"Opioids, chronic pain, and addiction in primary care." The journal of pain : official journal of the American Pain Society 11, no. 12 (2010): 1442-50. Abstract
"Integrating buprenorphine treatment into office-based practice: a qualitative study." Journal of general internal medicine 24, no. 2 (2009): 218-25. Abstract
"HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." Journal of acquired immune deficiency syndromes (1999) 56 Suppl 1 (2011): S22-32. Abstract
"The potential role of buprenorphine in the treatment of opioid dependence in HIV-infected individuals and in HIV infection prevention." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 43 Suppl 4 (2006): S178-83. Abstract
